Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial - Single lumen catheter versus double lumen catheter in hemodialysis trouble: Prospective, multicenter, open-label, randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044783

Enrollment

Registered

2021-07-31

Start date

2021-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ESRD

Interventions

Use of single lumen catheter in the six dialysis sessions Use of double lumen catheter in the six dialysis sessions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with end-stage renal disease who need blood purification therapy even temporarily and the doctor has determined that a non-cuff catheter needs to be inserted into the right internal jugular vein. (2) Of the above, patients who are expected to undergo hemodialysis for at least 2 weeks (6 times in total) after insertion. (3) Patients who have obtained written consent. (4) Adult patients.

Exclusion criteria

Exclusion criteria: (1) Patients with a catheter inserted in the intensive care unit. (2) Patients with severe congestive heart failure who require oxygen administration. (3) Patients whose doctor has determined that it is necessary to insert a lumen catheter that exceeds the double lumen. (4) Patients who the doctor has determined that a catheter needs to be inserted into a blood vessel other than the right internal jugular vein. (5) Patients who undergo special blood purification therapy such as plasma exchange. (6) Patients with infection. (7) Patients with cancer cachexia. (8) Patients with known coagulation abnormalities. (9) Patients who are using anticoagulants other than undifferentiated heparin and low molecular weight heparin during hemodialysis. (10) Patients with hybrid hemodialysis who perform peritoneal dialysis and weekly hemodialysis. (11) Other patients who the doctor in charge judged inappropriate to participate in this study.

Design outcomes

Primary

Measure	Time frame
incidence of blood removal failure in the six dialysis sessions after temporary catheter insertion	—

Secondary

Measure	Time frame
safety cost-effectiveness dialysis efficiency abnormal test value	—

Countries

Japan

Contacts

Public ContactTadashi Otsuka

Niigata University Medical and Dental Hospital Divison of nephrology and rheumatology

totogoal1230@gmail.com025-227-2200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026